Clinical Pathology: Transfusion Medicine

• Although the earliest hematopoietic progenitor cells (HPCs) do not express the A and/or B antigens, more committed cells of the erythroid lineage express these antigens.

• Delayed red blood cell engraftment is a potential adverse consequence of a major ABO incompatibility.

• Delayed engraftment is due to production anti-A and/or anti-B antibodies by residual plasma cells in the recipient that survive the preparative conditioning regimen.

In the context of a major ABO mismatched HPCtransplant, an acute hemolytic reaction at the time of HPC infusion may also occur due to the presence of ABO-incompatible red blood cells in the donor product and circulating anti-A and/or anti-B antibodies in the recipient.

Red blood cells can be depleted from the donor product in the setting of a major ABO mismatched HPCtransplant, typically by performing simple red cell depletion, density gradient red cell depletion, or CD34 selection.

Daniel-Johnson J, Schwartz J: How do I approach ABO-incompatible hematopoietic progenitor cell transplantation? Transfusion 2011;51:1143–1149.

 
* = Required 
* Note Title
* Note